The complement system: a potential target for stroke therapy.
Mocco
J
J
Department of Neurological Surgery, Columbia University, College of Physicians & Surgeons, New York, New York 10032, USA.
Sughrue
Michael E
ME
Ducruet
Andrew F
AF
Komotar
Ricardo J
RJ
Sosunov
Sergei A
SA
Connolly
E Sander
ES
D000818:Animals; D003167:Complement Activation; D051056:Complement Inactivating Agents / Q000378:metabolism / Q000627:therapeutic use; D003165:Complement System Proteins / Q000276:immunology*; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology*; D007511:Ischemia / Q000276:immunology / Q000473:pathology; D009422:Nervous System Diseases / Q000276:immunology / Q000473:pathology; D018696:Neuroprotective Agents / Q000276:immunology; D015427:Reperfusion Injury / Q000276:immunology; D020521:Stroke / Q000276:immunology / Q000473:pathology / Q000628:therapy
D051056:Complement Inactivating Agents; D007155:Immunologic Factors; D018696:Neuroprotective Agents; D003165:Complement System Proteins